{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:07:47Z","timestamp":1770505667417,"version":"3.49.0"},"reference-count":47,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2012,12,31]],"date-time":"2012-12-31T00:00:00Z","timestamp":1356912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2012,12,31]],"date-time":"2012-12-31T00:00:00Z","timestamp":1356912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"none reported"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Pulmonol."],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1002\/ppul.22745","type":"journal-article","created":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T20:16:10Z","timestamp":1357071370000},"page":"1190-1194","source":"Crossref","is-referenced-by-count":26,"title":["Clinical pharmacist impact on care, length of stay, and cost in pediatric cystic fibrosis (CF) patients"],"prefix":"10.1002","volume":"48","author":[{"given":"Jeffrey J.","family":"Cies","sequence":"first","affiliation":[{"name":"St. Christopher's Hospital for Children; Philadelphia; Pennsylvania"},{"name":"Drexel University College of Medicine; Philadelphia; Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie","family":"Varlotta","sequence":"additional","affiliation":[{"name":"St. Christopher's Hospital for Children; Philadelphia; Pennsylvania"},{"name":"Drexel University College of Medicine; Philadelphia; Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,12,31]]},"reference":[{"key":"10.1002\/ppul.22745-BIB0001|ppul22745-cit-0001","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/AAC.49.2.479-487.2005","article-title":"Aminoglycoside Resistance in Pseudomonas aeruginosa","volume":"49","author":"Poole","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/ppul.22745-BIB0002|ppul22745-cit-0002","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1054\/drup.2000.0152","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment","volume":"3","author":"Hancock","year":"2000","journal-title":"Drug Resist Update"},{"key":"10.1002\/ppul.22745-BIB0003|ppul22745-cit-0003","first-page":"560","article-title":"Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium","volume":"13","author":"Mesaros","year":"2007","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1002\/ppul.22745-BIB0004|ppul22745-cit-0004","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.ijantimicag.2007.06.015","article-title":"Pseudomonas aeruginosa bloodstream infections: how should we treat them","volume":"30","author":"van Delden","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1002\/ppul.22745-BIB0005|ppul22745-cit-0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro862","article-title":"Antimicrobial pharmacodynamics: critical interactions of bug and drug","volume":"2","author":"Drusano","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1002\/ppul.22745-BIB0006|ppul22745-cit-0006","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/344653","article-title":"Prevention of resistance: a goal for dose selection for antimicrobial agents","volume":"36","author":"Drusano","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1002\/ppul.22745-BIB0007|ppul22745-cit-0007","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","article-title":"Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration","volume":"155","author":"Moore","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1002\/ppul.22745-BIB0008|ppul22745-cit-0008","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/adc.67.1_Spec_No.57","article-title":"Pharmacokinetics and antibacterial activity of daily gentamicin","volume":"67","author":"Skopnik","year":"1992","journal-title":"Arch Dis Child"},{"key":"10.1002\/ppul.22745-BIB0009|ppul22745-cit-0009","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/infdis\/149.3.443","article-title":"The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia","volume":"149","author":"Moore","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1002\/ppul.22745-BIB0010|ppul22745-cit-0010","first-page":"9","article-title":"The effective use of gentamicin in life threatening sepsis","volume":"50","author":"Noone","year":"1974","journal-title":"Postgrad Med J"},{"key":"10.1002\/ppul.22745-BIB0011|ppul22745-cit-0011","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/AAC.13.4.570","article-title":"New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity","volume":"13","author":"Grasso","year":"1978","journal-title":"Antibact Agent Chemother"},{"key":"10.1002\/ppul.22745-BIB0012|ppul22745-cit-0012","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0140-6736(93)90137-6","article-title":"Once versus thrice daily gentamicin in patients with serious infections","volume":"341","author":"Prins","year":"1993","journal-title":"Lancet"},{"key":"10.1002\/ppul.22745-BIB0013|ppul22745-cit-0013","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/jac\/31.4.585","article-title":"Once-daily versus thrice-daily dosing of netilmicin in combination of B-lactam antibiotics as empirical therapy for febrile neutropenic patients","volume":"31","author":"Rozdinski","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/ppul.22745-BIB0014|ppul22745-cit-0014","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/bmj.312.7027.338","article-title":"Single or multiple daily doses of aminoglycosides: a meta-analysis","volume":"312","author":"Barza","year":"1996","journal-title":"Br Med J"},{"key":"10.1002\/ppul.22745-BIB0015|ppul22745-cit-0015","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/jac\/dkm097","article-title":"Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients","volume":"59","author":"Lam","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/ppul.22745-BIB0016|ppul22745-cit-0016","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1067\/mpd.2002.120269","article-title":"Cystic fibrosis: a 2002 update","volume":"140","author":"Orenstein","year":"2002","journal-title":"J Pediatr"},{"key":"10.1002\/ppul.22745-BIB0017|ppul22745-cit-0017","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1008634911114","article-title":"Clinical pharmacokinetics of antimicrobial drugs in cystic fibrosis","volume":"20","author":"Touw","year":"1998","journal-title":"Pharm World Sci"},{"key":"10.1002\/ppul.22745-BIB0018|ppul22745-cit-0018","first-page":"96-1-16","volume-title":"Applied therapeutics: the clinical use of drugs","author":"Koda-Kimble","year":"2001"},{"key":"10.1002\/ppul.22745-BIB0019|ppul22745-cit-0019","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00003088-199835060-00003","article-title":"Pharmacokinetic optimization of antibacterial treatment in patients with cystic fibrosis","volume":"35","author":"Touw","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/ppul.22745-BIB0020|ppul22745-cit-0020","first-page":"236","article-title":"Daily dosage of aminoglycosides","volume":"17","author":"Urban","year":"1997","journal-title":"Curr Clin Top Infect Dis"},{"key":"10.1002\/ppul.22745-BIB0021|ppul22745-cit-0021","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jps.2600680304","article-title":"Individualizing gentamicin dosage in burn patients with gram negative septicemia: a cost-benefit analysis","volume":"168","author":"Bootman","year":"1979","journal-title":"J Pharm Sci"},{"key":"10.1002\/ppul.22745-BIB0022|ppul22745-cit-0022","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1592\/phco.23.1.113.31910","article-title":"Evidence of the economic benefit of clinical pharmacy services: 1996-2000","volume":"23","author":"Schumock","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1002\/ppul.22745-BIB0023|ppul22745-cit-0023","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.282.3.267","article-title":"Pharmacist participation on physician rounds and adverse drug events in the intensive care unit","volume":"282","author":"Leape","year":"1999","journal-title":"JAMA"},{"key":"10.1002\/ppul.22745-BIB0024|ppul22745-cit-0024","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/j.1875-9114.1996.tb03049.x","article-title":"Economic evaluation of clinical pharmacy services-1988-1995","volume":"16","author":"Schumock","year":"1996","journal-title":"Pharmacotherapy"},{"key":"10.1002\/ppul.22745-BIB0025|ppul22745-cit-0025","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/archinte.159.16.1939","article-title":"Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure team","volume":"159","author":"Gattis","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1002\/ppul.22745-BIB0026|ppul22745-cit-0026","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.285.16.2114","article-title":"Medication errors and adverse drug events in pediatric inpatients","volume":"285","author":"Kaushal","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/ppul.22745-BIB0027|ppul22745-cit-0027","first-page":"2329","article-title":"Economic consequences of two drug-use control systems in a teaching hospital","volume":"45","author":"Clapham","year":"1988","journal-title":"Am J Hosp Pharm"},{"key":"10.1002\/ppul.22745-BIB0028|ppul22745-cit-0028","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/j.1875-9114.1996.tb03659.x","article-title":"The impact of clinical pharmacists on psychiatric patients","volume":"16","author":"Jenkins","year":"1996","journal-title":"Pharmacotherapy"},{"key":"10.1002\/ppul.22745-BIB0029|ppul22745-cit-0029","first-page":"1691","article-title":"Effect of advanced pharmaceutical services on the incidence of adverse drug reactions","volume":"36","author":"McKenney","year":"1979","journal-title":"Am J Hosp Pharm"},{"key":"10.1002\/ppul.22745-BIB0030|ppul22745-cit-0030","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/archinte.166.9.955","article-title":"Clinical pharmacists and inpatient medical care: a systematic review","volume":"166","author":"Kaboli","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1002\/ppul.22745-BIB0031|ppul22745-cit-0031","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1592\/phco.19.18.1354.30893","article-title":"Clinical pharmacy services, pharmacist staffing, and drug costs in United States hospitals","volume":"19","author":"Bond","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1002\/ppul.22745-BIB0032|ppul22745-cit-0032","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1592\/phco.20.7.609.35169","article-title":"Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals","volume":"20","author":"Bond","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1002\/ppul.22745-BIB0033|ppul22745-cit-0033","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1592\/phco.22.3.134.33551","article-title":"Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals","volume":"22","author":"Bond","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1002\/ppul.22745-BIB0034|ppul22745-cit-0034","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1592\/phco.21.13.1023.34617","article-title":"Medication errors in United States hospitals","volume":"21","author":"Bond","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1002\/ppul.22745-BIB0035|ppul22745-cit-0035","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1592\/phco.24.11.953.36133","article-title":"Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions","volume":"24","author":"Bond","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1002\/ppul.22745-BIB0036|ppul22745-cit-0036","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.2146\/ajhp040555","article-title":"Clinical and economic outcomes of pharmacist provided aminoglycoside or vancomycin management in hospitalized Medicare patients","volume":"62","author":"Bond","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"10.1002\/ppul.22745-BIB0037|ppul22745-cit-0037","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1592\/phco.26.6.735","article-title":"Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals","volume":"26","author":"Bond","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1002\/ppul.22745-BIB0038|ppul22745-cit-0038","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.med.56.082103.104356","article-title":"Therapeutic intervention and targets for sepsis","volume":"56","author":"Rice","year":"2005","journal-title":"Ann Rev Med"},{"key":"10.1002\/ppul.22745-BIB0039|ppul22745-cit-0039","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1097\/01.CCM.0000098031.24329.10","article-title":"Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis","volume":"31","author":"Garnacho-Montero","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1002\/ppul.22745-BIB0040|ppul22745-cit-0040","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.amjmed.2003.07.005","article-title":"Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis","volume":"115","author":"Harbarth","year":"2003","journal-title":"Am J Med"},{"key":"10.1002\/ppul.22745-BIB0041|ppul22745-cit-0041","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/01.CCM.0000045026.81584.6F","article-title":"Bacteremic sepsis in intensive care: temporal trends in incidence, organ dysfunction, and prognosis","volume":"31","author":"Hugonnet","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1002\/ppul.22745-BIB0042|ppul22745-cit-0042","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients","volume":"115","author":"Kollef","year":"1999","journal-title":"Chest"},{"key":"10.1002\/ppul.22745-BIB0043|ppul22745-cit-0043","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1002\/ppul.22745-BIB0044|ppul22745-cit-0044","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/infdis\/149.3.443","article-title":"The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia","volume":"149","author":"Moore","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1002\/ppul.22745-BIB0045|ppul22745-cit-0045","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0002-9343(84)90358-9","article-title":"Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia","volume":"77","author":"Moore","year":"1984","journal-title":"Am J Med"},{"key":"10.1002\/ppul.22745-BIB0046|ppul22745-cit-0046","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/INF.0b013e3181ff64ec","article-title":"Timing of correct parenteral antibiotic initiation,outcomes from severe bacterial community-acquired pneumonia in children","volume":"30","author":"Muszynski","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1002\/ppul.22745-BIB0047|ppul22745-cit-0047","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1542\/peds.103.3.594","article-title":"Once-versus twice-daily gentamicin dosing in neonates \u226534 weeks' gestation: cost-effectiveness analyses","volume":"103","author":"Thureen","year":"1999","journal-title":"Pediatrics"}],"container-title":["Pediatric Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fppul.22745","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fppul.22745","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/ppul.22745\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T04:32:09Z","timestamp":1714797129000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ppul.22745"}},"subtitle":["pharmacist impact in pediatric CF"],"short-title":[],"issued":{"date-parts":[[2012,12,31]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1002\/ppul.22745","archive":["Portico"],"relation":{},"ISSN":["8755-6863"],"issn-type":[{"value":"8755-6863","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12,31]]}}}